Psychometrics and diagnostics of the Italian version of the Alternate Verbal Fluency Battery (AVFB) in non-demented Parkinson's disease patients
- PMID: 38467953
- PMCID: PMC11255082
- DOI: 10.1007/s10072-024-07436-5
Psychometrics and diagnostics of the Italian version of the Alternate Verbal Fluency Battery (AVFB) in non-demented Parkinson's disease patients
Abstract
Background: Verbal fluency (VF) tasks are known as suitable for detecting cognitive impairment (CI) in Parkinson's disease (PD). This study thus aimed to evaluate the psychometrics and diagnostics of the Alternate Verbal Fluency Battery (AVFB) by Costa et al. (2014) in an Italian cohort of non-demented PD patients, as well as to derive disease-specific cut-offs for it.
Methods: N = 192 non-demented PD patients were screened with the Montreal Cognitive Assessment (MoCA) and underwent the AVFB-which includes phonemic, semantic and alternate VF tests (PVF; SVF; AVF), as well as a Composite Shifting Index (CSI) reflecting the "cost" of shifting from a single- to a double-cued VF task. Construct validity and diagnostics were assessed for each AVFB measure against the MoCA. Internal reliability and factorial validity were also tested.
Results: The MoCA proved to be strongly associated with PVF, SVF and AVF scores, whilst moderately with the CSI. The AVFB was internally consistent and underpinned by a single component; however, an improvement in both internal reliability and fit to its factorial structure was observed when dropping the CSI. Demographically adjusted scores on PVF, SVF and AVF tests were diagnostically sound in detecting MoCA-defined cognitive impairment, whilst this was not true for the CSI. Disease-specific cut-offs for PVF, SVF and AVF tests were derived.
Discussion: In conclusion, PVF, SVF and AVF tests are reliable, valid and diagnostically sound instruments to detect cognitive impairment in non-demented PD patients and are therefore recommended for use in clinical practice and research.
Keywords: Cognitive impairment; Language; Executive; Neuropsychology; Parkinson’s disease; Verbal fluency.
© 2024. The Author(s).
Conflict of interest statement
V. S. received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb S.r.l., Novartis Pharma AG and Zambon and receives or has received research supports from the Italian Ministry of Health, AriSLA and E-Rare Joint Transnational Call. He is in the Editorial Board of
Figures

Similar articles
-
Regression-based thresholds to detect clinical changes in verbal fluency after STN-DBS in Parkinson's disease.Parkinsonism Relat Disord. 2025 Mar;132:107300. doi: 10.1016/j.parkreldis.2025.107300. Epub 2025 Jan 31. Parkinsonism Relat Disord. 2025. PMID: 39908725
-
Validity and diagnostics of the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson's disease patients.Aging Clin Exp Res. 2023 Oct;35(10):2157-2163. doi: 10.1007/s40520-023-02493-w. Epub 2023 Jul 22. Aging Clin Exp Res. 2023. PMID: 37480503 Free PMC article.
-
Reliable change indices for the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson's disease patients.BMC Neurol. 2024 Nov 4;24(1):427. doi: 10.1186/s12883-024-03920-9. BMC Neurol. 2024. PMID: 39497078 Free PMC article.
-
Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson's disease.Appl Neuropsychol Adult. 2020 Sep-Oct;27(5):431-439. doi: 10.1080/23279095.2019.1565762. Epub 2019 Mar 1. Appl Neuropsychol Adult. 2020. PMID: 30821505
-
The Italian telephone-based Verbal Fluency Battery (t-VFB): standardization and preliminary clinical usability evidence.Front Psychol. 2022 Aug 3;13:963164. doi: 10.3389/fpsyg.2022.963164. eCollection 2022. Front Psychol. 2022. PMID: 35992426 Free PMC article.